IL19 and atherosclerosis: Together, these preliminary, but provocative, data suggest that IL-19 can decrease atherosclerosis in susceptible mice while neither affecting Th1 /Th2 balance nor suppressing serum lipid levels and place emphasis on vascular cells as the primary targets for IL-19.